An FDA advisory board recommended withdrawing government approval for the breast cancer drug, Avastin. Pros and cons of the decision and its implications for FDA’s accelerated approval process to treat serious and life threatening diseases.

Guests

  • Dr. Peter Bach attending physician and director of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering Cancer Center, and a former adviser to Medicare.
  • Dr. Carolyn Hendricks a medical oncologist affiliated with Suburban Hospital in Bethesda.
  • William Hubbard former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA
  • Gardiner Harris science reporter for "The New York Times" and author of the mystery novel 'Hazard.'

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

Rita Dove: “Collected Poems: 1974 – 2004”

Thursday, May 05 2016Rita Dove's poetry career has spanned more than forty years. During that time she won a Pulitzer Prize and became the first African-American poet laureate of the United States. Now she's released a new edition of collected works. Rita Dove on a life lived in verse.